For example, amplification of the HER2 gene is observed in ~30% of breast cancer biopsies and forms the basis for the use of trastuzumab (Herceptin, Genentech, Inc, California) to treat breast cancer patients. The gene discussed is ERBB2; the disease is breast cancer.